Evidence map›Paper›PMID 42209693›Full record

ArticleScientific reports2026

Superhydrophobic PTFE/MWCNT coatings fabricated by supercritical fluid processing with controlled wettability.

S Rajiv, S Murugesh

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

S RajivDepartment of Mechanical Engineering, E.G.S. Pillay Engineering College, Old Nagore Road, Nagapattinam, Tamil Nadu, 611002, India. rajivbrave@gmail.com.
S MurugeshDepartment of Mechanical Engineering, E.G.S. Pillay Engineering College, Old Nagore Road, Nagapattinam, Tamil Nadu, 611002, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Superhydrophobic PTFE/MWCNT composite coatings were fabricated via supercritical fluid processing followed by air-spray deposition to control hierarchical surface architectures. The composites were prepared at PTFE: MWCNT mass ratios (w/w) of 10:1, 10:2, and 10:3 (corresponding to ~ 9.1-23.1 wt% MWCNT) to conduct a more systematic evaluation of the influence of nanotube loading on surface morphology and wettability. Structural and chemical analyses (Raman, FTIR, XRD) confirmed the successful incorporation of MWCNTs without compromising the integrity of the PTFE matrix. Morphological characterization (FESEM, HRTEM, and AFM) confirmed the formation of interconnected micro-nano hierarchical features governed by nanotube dispersion and concentration. All coatings demonstrated superhydrophobic characteristics, with the highest water contact angle measuring 156.3° observed at the optimal 10:2 (w/w) composition. This performance is attributed to an optimal balance between surface roughness, uniform nanotube dispersion, and effective air entrapment within the hierarchical structure. The modulation of wettability was extended to the number of spray passes, with the second coating cycle being the most effective in surface architecture. Such observed behavior is supported by a structure-wettability correlation based on a hierarchical morphology and air fraction. These results demonstrate that supercritical fluid processing enables a coherent control of the nanotube dispersion, scalable fabrication of PTFE-based superhydrophobic coatings, and a robust processing-structure-property paradigm for designing advanced water-repellent surfaces.

Indexed as

Interfacial morphologyPTFE/MWCNT composite coatingsStructure–wettability correlationSupercritical fluid processingSuperhydrophobic surfaces

Identifiers

PMID42209693
PMCPMC13448703

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.